Titre (en)
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « Titre (en) » - entrée « agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
agent < agents < aggregation  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000010 (2020) Eric Toussirot [France]The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000027 (2020) Cécile Dumaine [France] ; Sara Bekkar [France] ; Alexandre Belot [France] ; Natalia Cabrera [France] ; Salma Malik [France] ; Annette Von Scheven [Suisse] ; Aurelia Carbasse [France] ; Andreas Woerner [Suisse] ; Carine Wouters [Belgique] ; Kenza Bouayed ; Pascal Pillet [France] ; Silke Schroeder [Suisse] ; Michael Hofer [Suisse] ; Véronique Hentgen [France]Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte.
000067 (2019) Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000113 (2019) Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France]Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
000159 (2018) Elodie Rivière [France] ; Jérémie Sellam [France] ; Juliette Pascaud [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France]Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
000198 (2018) K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne]ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
000257 (2017) L. Méry-Bossard [France] ; K. Bagny [France] ; G. Chaby [France] ; A. Khemis [France] ; F. Maccari [France] ; H. Marotte [France] ; J L Perrot [France] ; Z. Reguiai [France] ; M L Sigal [France] ; M. Avenel-Audran [France] ; T. Boyé [France] ; A. Grasland [France] ; J. Gillard [France] ; D. Jullien [France] ; E. Toussirot [France]New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.
000323 (2016) Josef S. Smolen [Autriche] ; Joel M. Kremer [États-Unis] ; Carol L. Gaich [États-Unis] ; Amy M. Delozier [États-Unis] ; Douglas E. Schlichting [États-Unis] ; Li Xie [États-Unis] ; Ivaylo Stoykov [États-Unis] ; Terence Rooney [États-Unis] ; Paul Bird [Australie] ; Juan Miguel Sánchez Burs N [Espagne] ; Mark C. Genovese [États-Unis] ; Bernard Combe [France]Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)
000325 (2016) Éric Toussirot [France] ; François Aubin [France]Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview
000332 (2016) Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
000443 (2014) Andreas Woerner [Suisse] ; Alexandre Belot [France] ; Etienne Merlin [France] ; Carine Wouters [Belgique] ; Gerald Berthet [Suisse] ; Anuela Kondi [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Elvira Cannizzaro [Suisse] ; Natalia Cabrera [France] ; Silke Schroeder [Suisse] ; Florence Aeschlimann [Suisse] ; Annette Von Scheven [Suisse] ; Agnès Duquesne [France] ; Samuel Roethlisberger [Suisse] ; Isabelle Kone-Paut [France] ; Michael Hofer [Suisse]Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium
000494 (2013) A. Woerner [Suisse, France] ; F. Uettwiller [France] ; I. Melki [France] ; B. Bader-Meunier [France] ; R. Mouy [France] ; C. Wouters [France] ; P. Quartier [France]PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
000526 (2013) B. Fautrel [France] ; J.-M. Joubert ; G. Cukierman ; C. Laurendeau ; J. Gourmelen [France] ; F. FagnaniTHU0512 Rheumatoid Arthritis (RA), Comorbidities and Biological Agents Uptake in France: Analysis of a National Claims Database
000572 (2013) A. Östör [Royaume-Uni] ; J. A. Román Ivorra [Espagne] ; J. Wollenhaupt [Allemagne] ; C. Mpofu [Suisse] ; C. Bernasconi [Suisse] ; J. Sibilia [France] ; V. Bykerk [États-Unis, Canada]FRI0179 Comparison of tocilizumab as monotherapy or in combination with non-biological disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to anti-TNF agents
000577 (2013) M. Schiff [États-Unis] ; W. Stam [Pays-Bas] ; I. Gilloteau ; C. Poncet [France] ; M. Hochberg [États-Unis]AB1359 Systematic literature review of publications on indirect comparisons for biologic agents in RA
000623 (2012) Cecilia Giampietro [Italie] ; Bruno Fautrel [France]Anti-Interleukin-1 Agents in Adult Onset Still's Disease
000659 (2011) Vincent André [France] ; Benoît Le Goff ; Christophe Leux ; Marianne Pot-Vaucel ; Yves Maugars ; Jean-Marie BerthelotInformation on glucocorticoid therapy in the main studies of biological agents.
000667 (2011) Patricia Guyot [Pays-Bas] ; Peter Taylor [Royaume-Uni] ; Robin Christensen [Danemark] ; Louisa Pericleous [Royaume-Uni] ; Coralie Poncet [France] ; Maximilian Lebmeier [Royaume-Uni] ; Pieter Drost [Belgique] ; Gert Bergman [Pays-Bas]Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
000699 (2011) Robert Launois [France] ; Bernard Avouac ; Francis Berenbaum ; Olivier Blin ; Isabelle Bru ; Bruno Fautrel ; Jean-Michel Joubert ; Jean Sibilia ; Bernard CombeComparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis
000726 (2009) Angélique Gougelet [France] ; Adeline Mansuy [France] ; Jean-Yves Blay [France, Belgique] ; Laurent Alberti [France] ; Claudine Vermot-Desroches [France]Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti–IL-6 Antibody

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i -k "agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i  \
                -Sk "agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    agents
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021